IP Library Granted Patent US 11,136,560
Granted Patent B2
US 11,136,560 · App. 15/947,220 · Granted Oct 5, 2021

Pipecolinic acid 4-hydroxylase and method for producing 4-hydroxy amino acid using same

Inventors: Makoto Hibi (Kyoto, JP); Jun Ogawa (Kyoto, JP); Ryoma Miyake (Kanagawa, JP); Hiroshi Kawabata (Kanagawa, JP)
Assignee: API CORPORATION
C12N9/0071C12N1/20C12P13/04C12P17/10C12P17/12C12Y114/00C12Y114/11006H05K999/99
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,136,560
App. No.
15/947,220
Granted
Oct 5, 2021
Kind
B2
Abstract

The present invention provides a pipecolic acid 4-hydroxylase protein exemplified by the following (A), (B), and (C), having activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions to produce trans-4-hydroxy-L-pipecolic acid, and a method for producing 4-hydroxy amino acid, which method comprises reacting the pipecolic acid 4-hydroxylase protein, cells containing the protein, a treated product of the cells, and/or a culture liquid obtained by culturing the cells, with α-amino acid to produce 4-hydroxy amino acid: (A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18; (B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18 except that one or several amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity; and (C) a polypeptide having an amino acid sequence that is not less than 80% identical to the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18, and having pipecolic acid 4-hydroxylase activity.

Claims (16)

1. A pipecolic acid 4-hydroxylase protein having an activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions, to produce trans-4-hydroxy-L-pipecolic acid,

wherein the pipecolic acid 4-hydroxylase protein is selected from the group consisting of the following (A), (B-1), (B-2), (B-3), (B-4), (C-1), and (C-2), and the pipecolic acid 4-hydroxylase protein is a recombinant non-glycosylated protein:

(A) a polypeptide comprising the amino acid sequence of SEQ ID NO: 16 or 18;

(B-1) a polypeptide comprising the amino acid sequence of SEQ ID NO: 4, 6, 12, or 18 except that one to ten amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity;

(B-2) a polypeptide comprising the amino acid sequence of SEQ ID NO: 2 except that one to five amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity;

(B-3) a polypeptide comprising the amino acid sequence of SEQ ID NO: 8 or 10 except that one amino acid is deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity;

(B-4) a polypeptide comprising the amino acid sequence of SEQ ID NO: 16 except that one to five amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity;

(C-1) a polypeptide comprising an amino acid sequence that is not less than 80% but not 100% identical to the amino acid sequence of SEQ ID NO: 4, 6, 12, or 18, and having pipecolic acid 4-hydroxylase activity; and

(C-2) a polypeptide comprising an amino acid sequence that is not less than 95% but not 100% identical to the amino acid sequence of SEQ ID NO: 2, and having pipecolic acid 4-hydroxylase activity.

2. A microorganism having no glycosylation ability transformed with a DNA encoding a pipecolic acid 4-hydroxylase protein selected from the group consisting of the following (D), (E-1), (E-2), (E-3), and (E-4):

(D) a DNA comprising the nucleotide sequence of SEQ ID NO: 15 or 17;

(E-1) a DNA comprising the nucleotide sequence of SEQ ID NO: 3, 5, 11, or 17 except that one to three nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity;

(E-2) a DNA comprising the nucleotide sequence of SEQ ID NO: 1 except that one to three nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity;

(E-3) a DNA comprising the nucleotide sequence of SEQ ID NO: 7 or 9 except that one nucleotide is substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity; and

(E-4) a DNA comprising the nucleotide sequence of SEQ ID NO: 15 except that one to three nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity.

3. The microorganism according to claim 2 , which is selected from the group consisting of the genera Escherichia, Bacillus, Pseudomonas , and Corynebacterium.

Assignments (3)
CHANGE OF ADDRESS Recorded Aug 21, 2025
From: API CORPORATION
To: API CORPORATION
Reel/Frame 072498/0511 →
MERGER Recorded Aug 21, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 072554/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: HIBI, MAKOTO; OGAWA, JUN; MIYAKE, RYOMA; KAWABATA, HIROSHI
To: API CORPORATION
Reel/Frame 045464/0001 →
Priority Claims (1)
JP 2014-017716 · Jan 31, 2014 · national
Continuity (2)
Division 15115028
Related Publication 20180282709A1 · Oct 4, 2018